TrueBlue, Inc. (TBI)

NYSE: TBI · USD

$9.69

+0.01 (+0.1%)· Recorded snapshot

Market cap	295M
Revenue (ttm)	1.7B
Net income (ttm)	-56.6M
EPS (ttm)	-$1.88
Shares out	30.4M
P/E (forward)	18.3x
Volume	208,809
Beta	1.72

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7B
Net income (ttm): -56.6M
EPS (ttm): -$1.88
P/E (forward): 18.3x
Market cap: 295M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	Mantenere
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	Mantenere
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-20.2

P25 n/aP50 n/aP75 n/a

ROIC-7.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TBI indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

USD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000768899
Company name	TrueBlue, Inc.
Country	United States
Country code	US
CUSIP number	89785X101
Earnings date	2026-11-04
Earnings time	amc
Employees	3,500
Employees change	-700
Employees growth	-16.67%
Enterprise value	$410.2M
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-28
First seen	2026-05-09
Fiscal year end	December
Founded	1985
In index	RUSSELL2000
Industry	Staffing & Employment Services
IPO date	1996-06-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US89785X1019
Last 10-K release date	2026-02-18
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	1999-07-13
Last stock split type	Forward
Market cap	$295M
Market cap category	Micro-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$9.69
Price currency	USD
Sector	Industrials
SIC code	7363
Stock price date	2026-10-28
Symbol	TBI
U.S. state	Washington
Website	https://www.trueblue.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-19.41%
EV/EBITDA	594.04x
EV/Sales	0.24x
FCF / EV yield	-16.45%
FCF yield	-22.88%
Forward EV/Sales	0.23x
Forward P/E	18.26x
Forward P/S	0.17x
Industry forward P/E	15.87x
P/B ratio	1.16x
P/S ratio	0.17x
PEG ratio	1.3x
Price / tangible book value	1.48x
Price/EBITDA ratio	427.1x
Sector forward P/E	26.03x
Sector P/E	40.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-1.63%
EBITDA margin	0.04%
Gross margin	21.52%
Operating margin	-1.63%
Pretax margin	-3.16%
Profit margin	-3.35%
Profit per employee	$-16,176
Revenue per employee	$483,146
ROA	-2.66%
ROA (5Y)	0.21%
ROCE	-5.69%
ROE	-20.23%
ROE (5Y)	-5.18%
ROIC	-7.52%
ROIC (5Y)	0.29%
SBC / revenue	0.4%
Tax / revenue	0.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	-2.67%
Gross profit growth (Q)	7.75%
Gross profit growth 3Y	-13.25%
Gross profit growth 5Y	-5.32%
Net income growth years	1
Revenue growth	10.17%
Revenue growth (Q)	11.79%
Revenue growth (QoQ)	11.15%
Revenue growth 10Y	-4.96%
Revenue growth 3Y	-6.58%
Revenue growth 5Y	-2.99%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-12.9M
Depreciation and amortization	$28.2M
EBIT	$-27.5M
EBITDA	$690,000
EPS	$-1.88
FCF per share	$-2.22
Financing cash flow	$27.7M
Free cash flow	$-67.4M
Free cash flow minus SBC	$-74.1M
Gross profit	$363.9M
Income taxes	$3.3M
Investing cash flow	$13.8M
Net borrowing	$28.6M
Net cash flow	$-13.5M
Net income	$-56.6M
Operating cash flow minus SBC	$-61.2M
Operating income	$-27.5M
Revenue	$1.7B
Stock-based compensation	$6.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.79
Book value per share	$8.37
Debt / EBITDA	6.12
Debt / equity	0.54
Goodwill	$38.9M
Interest coverage	-4
Long-term assets	$304.6M
Long-term liabilities	$228.9M
Net cash (debt)	$-115.2M
Net cash / market cap	-39.09%
Net debt / EBITDA	166.94
Net debt / equity	0.45
Piotroski F-Score	3
Property, plant and equipment	$99.1M
Shareholders' equity	$254.7M
Tangible book value	$199M
Tangible book value per share	$6.54
Total assets	$623M
Total cash	$23.3M
Total debt	$138.4M
Total liabilities	$368.3M
WACC	10.6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	2.61
Current assets	$318.4M
Current liabilities	$139.4M
Current ratio	2.28
Net working capital	$167.1M
Quick ratio	2.1
Working capital	$179M
Working capital turnover	10.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.34%
Dividend yield	0%
Shareholder yield	-1.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-42.45%
10Y return CAGR	-5.38%
10Y total return	-42.45%
150-day SMA	$7.50
15Y price change	-32.49%
15Y return CAGR	-2.59%
15Y total return	-32.49%
1D price change	0.1%
1M price change	2.12%
1M total return	2.12%
1W price change	16.29%
1W total return	16.29%
1Y price change	63.67%
1Y return CAGR	63.72%
1Y total return	63.67%
20-day SMA	$8.96
200-day SMA	$6.74
20Y price change	-44.6%
20Y return CAGR	-2.91%
20Y total return	-44.6%
3M price change	23.59%
3M total return	23.59%
3Y price change	-10.91%
3Y return CAGR	-3.78%
3Y total return	-10.91%
50-day SMA	$9.46
50-day SMA vs 200-day SMA	50over200
52-week high	$11.03
52-week high date	2026-08-19
52-week low	$3.18
52-week low date	2026-03-30
5Y price change	-65.57%
5Y return CAGR	-19.21%
5Y total return	-65.57%
6M price change	103.81%
6M total return	103.81%
All-time high	$32.91
All-time high date	2021-10-25
All-time low	$1.93
All-time low date	1997-04-15
Average true range (ATR)	$0.44
Average volume	196.2K
Beta (1Y)	2.51
Beta (2Y)	1.58
Beta (5Y)	1.72
Change from 52-week high	-12.15%
Change from 52-week low	204.72%
Change from all-time high	-70.71%
Change from all-time low	400.52%
Change from open	-0.41%
Day's gap	0.52%
Dollar volume	$2M
High price	$9.73
Low price	$9.42
Monthly RSI	55.98
Open price	$9.73
Position in 52-week range	87.1%
Premarket change	0%
Premarket close	$9.68
Premarket price	$9.68
Previous close	$9.68
Price vs 150-day SMA	28.62%
Price vs 20-day SMA	7.59%
Price vs 200-day SMA	43.05%
Price vs 50-day SMA	1.92%
Relative volume	1.06
RSI	58.91
Sharpe ratio	0.97
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	-0.22
Sortino ratio	1.84
Sortino ratio (3Y)	0.19
Sortino ratio (5Y)	-0.21
Volume	208.8K
Weekly RSI	60.65
YTD price change	111.87%
YTD total return	111.87%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27.6M
Float percentage	90.81%
Shares change (QoQ)	0.89%
Shares change (YoY)	1.34%
Shares held by insiders	4.97%
Shares held by institutions	81.62%
Shares outstanding	30.4M
Short % of float	2.36%
Short % of shares	2.14%
Short ratio	2.1 days

Deeper analysis on TBI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TBI report

Is a complete TBI research report available?

No complete published report is available for TrueBlue, Inc. (TBI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TrueBlue, Inc. (TBI)

Price

Financial snapshot

Fair-value bridge

Latest news · TBI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TBI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TBI

Frequently asked questions